Renaissance Capital logo

Advanced Biomed Filed Terms, Nasdaq: ADVB

Taiwanese developer of microfluidic testing equipment for early cancer screening.

Industry: Health Care

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Health Care

We are a holding company incorporated in the State of Nevada. We operate through Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. Advanced Biomed Taiwan is responsible for the main operation and the design and development of the company's primary technologies and products. Since our establishment in 2014, we have been focusing on the integration of multiple interdisciplinary technologies and established our own microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, we have developed various advanced and original research through the joint application of semiconductor technology and biotechnology. This includes complex precision structures, dielectric detection, functional microfluidic biochips, microfluidic integrated semiconductor sensors, related application modules, and key components of medical testing equipment. We have also developed a series of medical testing equipment and related products by integrating various functions of microfluidic modules, automation software, and hardware. Our technologies and products can be used for early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers in blood samples, capture of single circulating tumor cells, and single-cell sorting and determination.
more less
IPO Data
IPO File Date 05/22/2023
Offer Price
Price Range $4.00 - $6.00
Offer Shares (mm) 1.9
Deal Size ($mm) $9
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $4.00 - $6.00
Offer Shares (mm) 1.9
Deal Size ($mm) $9
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Craft Capital Management
Company Data
Headquarters Tainan, Taiwan
Founded 2014
Employees at IPO 40
Website www.advanbiomed.com

Advanced Biomed (ADVB) Performance